Fleury SA
BOVESPA:FLRY3
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Fleury SA
Revenue
Fleury SA
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Fleury SA
BOVESPA:FLRY3
|
Revenue
R$7.1B
|
CAGR 3-Years
31%
|
CAGR 5-Years
21%
|
CAGR 10-Years
16%
|
|
Oncoclinicas do Brasil Servicos Medicos SA
BOVESPA:ONCO3
|
Revenue
R$5.5B
|
CAGR 3-Years
39%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
Centro de Imagem Diagnosticos SA
BOVESPA:AALR3
|
Revenue
R$1.2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
D
|
Diagnosticos da America SA
BOVESPA:DASA3
|
Revenue
R$14.4B
|
CAGR 3-Years
22%
|
CAGR 5-Years
29%
|
CAGR 10-Years
19%
|
See Also
What is Fleury SA's Revenue?
Revenue
7.1B
BRL
Based on the financial report for Mar 31, 2024, Fleury SA's Revenue amounts to 7.1B BRL.
What is Fleury SA's Revenue growth rate?
Revenue CAGR 10Y
16%
Over the last year, the Revenue growth was 55%. The average annual Revenue growth rates for Fleury SA have been 31% over the past three years , 21% over the past five years , and 16% over the past ten years .